DISCOUNT CALL-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE Stock

Certificat

DE000PN95UM9

Delayed Deutsche Boerse AG 10:21:11 2024-05-28 EDT
1.85 EUR +5.71% Intraday chart for DISCOUNT CALL-OPTIONSSCHEIN - FRESENIUS MEDICAL CARE
Current month-7.89%
1 month+23.24%
Date Price Change
24-05-28 1.85 +5.71%
24-05-27 1.75 -4.89%
24-05-24 1.84 +16.46%
24-05-23 1.58 -9.71%
24-05-22 1.75 -15.05%

Delayed Quote Deutsche Boerse AG

Last update May 28, 2024 at 10:21 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN95UM
ISINDE000PN95UM9
Date issued 2023-10-24
Strike 40
Maturity 2024-09-20 (115 Days)
Parity 1 : 1
Emission price 0.92
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.5
Lowest since issue 0.79
Spread 0.01
Spread %0.52%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.77 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.77%
Consensus